Ceretrieve Announces Groundbreaking Success in FIH Ischemic Stroke Cases
Ceretrieve’s aspiration catheter demonstrated clots removal, completely restoring blood flow in a single pass.
YOKNEAM, Israel, May 28, 2024 /PRNewswire/ — Ceretrieve announced today the successful results of the company’s multicenter, single-arm study, showcasing the capabilities of its state-of-the-art aspiration catheter. The study, conducted across two centers, included 20 patients who suffered from acute ischemic stroke (AIS) due to intracranial large vessel occlusion (LVO) and were eligible for thrombectomy within 24 hours of symptom onset. The study was aimed for assessing the safety and initial performance of the Ceretrieve Device.
Related news for (TRNLY)
- Dasyo Welcomes Medical Aesthetics Industry Icon Domenic (Dom) Serafino as Executive Chair
- Limaca Medical Completes 24 EUS Pancreatic and Liver Biopsy Cases
- ZygoFix Receives FDA Clearance for its zLOCK Lumbar Facet Fixation System
- Vessi Medical Closes $16.5 Million Series A Round for Innovative Cryotherapy Bladder Cancer Treatment